

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Asciminib ni umuti wagenewe kurwanya kanseri ugamije kuvura ubwoko bwihariye bwa kanseri y'amaraso yitwa kanseri ya 'chronic myeloid leukemia' (CML). Ubu buvuzi bushya bukora mu buryo butandukanye n'imiti isanzwe ya CML, buhagarika selile za kanseri mu buryo bwihariye, butanga icyizere ku bantu kanseri yabo ititabiriye neza izindi nshuti.
Niba wowe cyangwa umuntu ukwitaho yarandikiwe asciminib, birashoboka ko ushaka amakuru asobanutse kandi afasha ku byo witegura. Reka tunyure mu bintu byose ukeneye kumenya kuri uyu muti mu buryo bworoshye.
Asciminib ni umuti wandikirwa na muganga wo mu cyiciro cy'imiti yitwa tyrosine kinase inhibitors. Tekereza nk'urufunguzo rwihariye rufunga kuri selile za kanseri kugira ngo zihagarare gukura no gukwirakwira mu mubiri wawe.
Uyu muti watejwe imbere by'umwihariko ku bantu bafite kanseri ya 'chronic myeloid leukemia', ubwoko bwa kanseri y'amaraso igira ingaruka ku bushobozi bw'amagufa yawe bwo gukora selile z'amaraso nziza. Igikora asciminib kuba umwihariko ni uko igamije igice gitandukanye cya selile ya kanseri ugereranije n'indi miti ya CML, ibyo bishobora gufasha iyo izindi nshuti zitakoze neza nk'uko byari byitezwe.
Asciminib ikoreshwa cyane cyane mu kuvura kanseri ya 'chronic myeloid leukemia' mu gihe cyayo kirambye, cyane cyane ku bantu bakuru kanseri yabo ititabiriye neza imiti ibiri cyangwa irenga yabanje. Muganga wawe ashobora no kuyikwandikira niba ufite ihinduka ryihariye rya genetike ryitwa T315I mutation rituma indi miti idakora neza.
Uyu muti ufatwa nk'ubuvuzi bugamije, bivuze ko wagenewe kurwanya ibintu byihariye by'uturemangingo twa kanseri mugihe turemangingo twiza tutagize icyo tubaho. Muganga wawe w'inzobere mu by'indwara z'umubiri (oncologist) azemeza niba asciminib ikwiriye imiterere yawe yihariye ashingiye ku mateka yawe y'ubuvuzi, imiti wakoresheje mbere, n'ibimenyetso byihariye bya genetike bya kanseri yawe.
Asciminib ikora ibungabunga poroteyine yitwa BCR-ABL1, ifite inshingano yo kubwira turemangingo twa kanseri gukura no kwiyongera mu buryo budateganijwe. Bitandukanye n'indi miti ya CML igamije ahantu hakora ka poroteyine, asciminib ifatana n'ahantu hatandukanye, bituma ikora neza kabone n'iyo turemangingo twa kanseri twaba twarwanye imiti yindi.
Uyu muti ufatwa nk'ukomeye kandi ugamije cyane. Ukomereza mu buryo bwihariye ibimenyetso turemangingo twa kanseri dukoresha kugirango tubashe kubaho no kwiyongera, mu by'ukuri bigashyira feri ku mikurire y'uturemangingo twa kanseri. Uburyo bugamije busobanura ko bushobora gukora neza mugihe gishobora gutera ingaruka nke ugereranije n'ubuvuzi bwa shimi (chemotherapy) bwagutse.
Fata asciminib nkuko muganga wawe abitegeka, akenshi rimwe cyangwa kabiri ku munsi bitewe na gahunda yawe y'ubuvuzi. Urashobora kuyifata hamwe cyangwa utayifatanije n'ibiryo, ariko gerageza kuyifata ku gihe kimwe buri munsi kugirango ugumane urwego rwo hejuru mu mubiri wawe.
Mimina ibinini byose hamwe n'ikirahure cy'amazi. Ntugasya, ntukore, cyangwa ubigabanye, kuko ibi bishobora kugira ingaruka ku buryo umuti winjizwa. Niba ugira ikibazo cyo kumira ibinini, ganira n'ikipe yawe y'ubuzima kubijyanye n'ingamba zishobora gufasha.
Muri rusange biragenda neza gufata ifunguro rito mbere yo gufata asciminib, ariko irinda urubuto rwa pome n'umutobe warwo, kuko ibi bishobora kubangamira uburyo umubiri wawe ukoresha umuti. Muganga wawe ashobora kandi kugusaba kwirinda indi miti cyangwa ibyongerera imbaraga bishobora guhura na asciminib.
Igikoresho cya asciminib gitinda cyane ku muntu ku muntu kandi biterwa n'uburyo kanseri yawe yitwara ku muti. Abantu benshi barwaye CML bakeneye gufata imiti igamije nk'asciminib mu gihe kirekire, rimwe na rimwe imyaka, kugira ngo bagumane kanseri yabo.
Muganga wawe azakurikiza uko witwara binyuze mu bipimo by'amaraso bisanzwe no gusuzuma umushongi w'amagufa. Ibi bizafasha kumenya niba umuti ukora neza kandi niba ushobora gukomeza urugero rumwe cyangwa ukeneye guhindura.
Ntuzigere uhagarika gufata asciminib ako kanya cyangwa guhindura urugero rwawe utabanje kubaza ikipe yawe y'ubuzima. N'iyo wumva umeze neza, umuti urashobora kuba ugikora kugira ngo ugumane selile za kanseri. Muganga wawe azakuyobora mu byemezo byose bijyanye no gukomeza, guhindura, cyangwa guhagarika imiti bitewe n'uburyo wabyitwayemo.
Kimwe n'imiti yose, asciminib irashobora gutera ingaruka, nubwo atari buri wese uzibona. Ingaruka nyinshi zishobora gucungwa neza no gukurikiranwa neza no gufashwa n'ikipe yawe y'ubuzima.
Dore ingaruka zisanzwe ushobora guhura nazo mugihe ufata asciminib:
Izi ngaruka zisanzwe zikunda kuba zoroshye kugeza ku gicucu kandi akenshi zirushaho uko umubiri wawe wimenyereza umuti. Ikipe yawe y'ubuzima irashobora gutanga ingamba zo gufasha gucunga neza ibi bimenyetso.
Nubwo bitari bisanzwe, hariho ingaruka zimwe zikomeye zisaba ubufasha bwihuse bw'ubuvuzi:
Niba ubonye kimwe muri ibi bimenyetso bikomeye, vugana n'umuganga wawe ako kanya cyangwa ushake ubufasha bwihutirwa. Itsinda ryawe ry'abaganga rirahari kugira ngo rigufashe guhangana n'ingaruka zose zishobora guterwa n'imiti mu buryo bwizewe.
Asciminib ntabwo ikwiriye kuri buri wese, kandi muganga wawe azasuzuma neza niba ari wo muti ukwiriye kuri wowe. Abantu bafite indwara zimwe na zimwe cyangwa abafata imiti imwe na imwe bashobora gukenera izindi miti.
Ntugomba gufata asciminib niba ufite allergie ikomeye izwi ku muti cyangwa ibikoresho byawo byose. Byongeye kandi, abantu bafite indwara zimwe na zimwe z'umutima, ibibazo bikomeye by'umwijima, cyangwa amateka ya pankereyasi bashobora gukenera gukurikiranwa byihariye cyangwa izindi miti.
Abagore batwite ntibagomba gufata asciminib kuko ishobora kwangiza umwana ukiri mu nda. Niba uteganya gutwita, utwite, cyangwa wonka, ganira n'ikipe yawe y'ubuzima ku zindi nzira zizewe. Abagabo n'abagore bagomba gukoresha uburyo bwiza bwo kuboneza urubyaro mugihe bafata uyu muti.
Asciminib iboneka ku izina ry'ubwoko rya Scemblix. Uyu muti w'izina ry'ubwoko ukorwa na Novartis kandi ni wo muti wenyine wa asciminib uboneka muri iki gihe mu bihugu byinshi.
Igihe uzaba wakiriye urupapuro rwawe rw'umuti, uzabona "Scemblix" ku icupa ry'umuti hamwe n'izina rusange "asciminib." Amazina yombi yerekeza ku muti umwe, bityo ntugire impungenge niba ubonye izina ryose rikoreshwa n'ikipe yawe y'ubuzima cyangwa farumasi.
Hariho izindi imiti myinshi ikoreshwa mu kuvura kanseri ya chronic myeloid leukemia, nubwo guhitamo biterwa n'uko ubuzima bwawe bumeze, imiti wabanje gufata, n'uburyo kanseri yawe yitwaye. Mu miti ikoreshwa cyane harimo imatinib (Gleevec), dasatinib (Sprycel), nilotinib (Tasigna), na bosutinib (Bosulif).
Buri muti muri iyi ikora mu buryo butandukanye kandi ishobora kuba ikwiriye cyangwa idakwiriye bitewe n'uko ubuzima bwawe bumeze. Abantu bamwe batangira gufata umuti umwe hanyuma bakawuhindura niba uwo bafashe utagize icyo utanga cyangwa ugatera ingaruka zikomeye.
Umuhanga wawe mu kuvura kanseri azakorana nawe kugirango amenye uburyo bwiza bwo kuvura bushingiye ku bintu nk'imiterere ya kanseri yawe, ubuzima bwawe muri rusange, indi miti ufata, n'amateka yawe y'imiti. Intego ni ukubona imiti ikora neza kandi itagira ingaruka zikomeye ku buzima bwawe.
Asciminib na imatinib bikora mu buryo butandukanye, kandi uwo ari wo mwiza biterwa n'uko ubuzima bwawe bumeze. Imatinib (Gleevec) akenshi ni umuti wa mbere ukoreshwa mu kuvura CML yatangiye kuvurwa, naho asciminib akenshi igenewe abantu batitabiriye neza indi miti.
Asciminib ishobora kuba ikora neza ku bantu kanseri yabo yagize ubwirinzi kuri imatinib cyangwa indi miti ya mbere. Ifata selile za kanseri ikoresheje uburyo butandukanye, bushobora kuba bwiza iyo imiti isanzwe itagikora neza.
Ariko, imatinib ifite amateka maremare kandi y'ubushakashatsi bwerekana uko ikora neza, cyane cyane ku bantu bashya bafite CML. Muganga wawe azatekereza ku bintu nk'amateka yawe y'imiti, ibimenyetso bya genetike, ingaruka ziterwa n'umuti, n'ubuzima bwawe muri rusange mugihe afata icyemezo cy'umuti ukwiriye kuri wowe.
Asciminib isaba gukurikiranwa neza ku bantu bafite indwara z'umutima. Uyu muti ushobora kugira ingaruka ku mutima n'umuvuduko w'amaraso, bityo muganga wawe ashobora gushaka gukora ibizamini by'imikorere y'umutima buri gihe niba ufite amateka y'indwara z'umutima.
Niba ufite ibibazo by'umutima, ntugatekereze ko udashobora gufata asciminib. Abantu benshi bafite indwara z'umutima bashobora gukoresha uyu muti neza hamwe no gukurikiranwa neza n'ingamba zikwiye. Umuganga w'umutima wawe n'umuganga w'indwara z'umutima bazakorana kugira ngo barebe ko ubuvuzi bwawe bufite akamaro kandi butagira ingaruka ku buzima bw'umutima wawe.
Niba ufata asciminib nyinshi ku buryo butunguranye kuruta uko byategetswe, vugana n'umuganga wawe cyangwa ikigo gishinzwe ubumara ako kanya. Ntuzategereze ngo urebe niba wumva ibimenyetso, kuko kubona inama z'ubuvuzi vuba ni bwo buryo bwiza buri gihe.
Mugihe utegereje ubuyobozi bw'ubuvuzi, ntugerageze kwivugisha umuriro keretse niba ubitegetswe byumwihariko. Bika urupapuro rw'umuti hamwe nawe kugirango ushobore kubwira abaganga neza icyo wafashe n'igihe. Gufata imiti myinshi ku buryo butunguranye bishobora gucungwa neza hamwe n'ubuvuzi bukwiye.
Niba wibagiwe gufata urugero rwa asciminib, ifate ako kanya wibukiye, keretse igihe cyo gufata urugero rwawe rutaha kigeze. Muricyo gihe, reka urugero wibagiwe ukomeze gahunda yawe isanzwe. Ntukigere ufata urugero ebyiri icyarimwe kugirango usubize urugero wibagiwe.
Niba ukunda kwibagirwa urugero, tekereza gushyiraho ibyibutso kuri terefone cyangwa gukoresha umuteguro w'imiti kugirango ugufashe kuguma ku murongo. Igihe cyo gufata imiti buri gihe gifasha kugumana urwego ruzigama mu mubiri wawe, ibyo bikaba by'ingenzi ku mikorere y'umuti.
Umutuzo wo guhagarika gufata asciminib ugomba gufatirwa hamwe n'umuganga wawe w'indwara z'umuvuduko w'amaraso, ntabwo wenyine. Muganga wawe azagenzura uko witwara ku buvuzi binyuze mu bipimo by'amaraso bya buri gihe kandi agasobanura igihe bishobora kuba byiza gutekereza guhagarika cyangwa kugabanya imiti.
Abantu bamwe bashobora guhagarika ubuvuzi niba bageze ku gisubizo cyimbitse cya molekile kandi bakagikomeza igihe runaka. Ariko, iki cyemezo gisaba kugenzura neza no gukurikiranwa. Abantu benshi barwaye CML bakeneye gukomeza ubuvuzi igihe kirekire kugirango bagumane kanseri yabo mu buryo bwiza.
Asciminib irashobora guhura n'indi miti itandukanye, bityo ni ngombwa kubwira ikipe yawe y'ubuzima ibintu byose urimo gufata, harimo imiti yanditswe na muganga, imiti itagurishwa ku isoko, n'ibyongerera imiti. Imiti imwe irashobora kongera cyangwa kugabanya imikorere ya asciminib cyangwa ikongera ibyago byo kugira ingaruka ziterwa n'iyo miti.
Imiti isanzwe ishobora guhura harimo imiti imwe ya antibiyotike, imiti irwanya fungus, imiti irwanya ibyuririzi, na imiti imwe y'umutima. Umufarumasiti wawe n'umuganga bazasuzuma imiti yawe yose kugirango barebe ko ari byiza kuyifata hamwe kandi bashobora gukenera guhindura doze cyangwa igihe cy'indi miti.
Get clear medical guidance
on symptoms, medications, and lab reports.